Silencing of Acyl-CoA Thioesterase 7 Inhibits Proliferation and Metastatic Potential in Colorectal Cancer Cells

Sumi Lee1, Jae Woong Koh2, Jung-Hee Lee1

  • 1Department of Cellular and Molecular Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Anticancer Research
|August 1, 2025
PubMed
Abstract

Insights

Acyl-CoA thioesterase 7 (ACOT7) is overexpressed in colorectal cancer (CRC) and drives tumor growth and metastasis. Silencing ACOT7 inhibits CRC cell proliferation, survival, and invasion, suggesting it as a therapeutic target.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • Acyl-CoA thioesterase 7 (ACOT7) is implicated in various cancers.
  • Its specific role in colorectal cancer (CRC) is not well understood.

Purpose of the Study:

  • To investigate the functional role of ACOT7 in colorectal cancer.
  • To assess ACOT7's impact on CRC cell behavior and metastatic potential.

Main Methods:

  • Examined ACOT7 expression in normal and CRC cells using qRT-PCR and Western blotting.
  • Utilized siRNA to knockdown ACOT7 and assessed effects on proliferation, clonogenicity, cell cycle, apoptosis, migration, and invasion.

Main Results:

  • ACOT7 expression was significantly elevated in CRC cells at both mRNA and protein levels.
  • ACOT7 knockdown reduced cell proliferation, clonogenicity, and induced apoptosis.
  • Suppression of ACOT7 impaired cell migration and invasion, indicating a role in metastasis.

Conclusions:

  • ACOT7 is a critical regulator of proliferation, survival, and metastasis in CRC.
  • ACOT7 represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K